摘要
目的:观察中西医结合治疗慢性肾盂肾炎的临床疗效。方法:将82例慢性肾盂肾炎患者随机分为2组,对照组采用常规西医治疗;观察组在对照组治疗基础上给予自拟肾通淋汤治疗。2周为1疗程,治疗3疗程。观察2组治疗后血尿氮素(BUN)、肌酐(SCr)、内生肌酐清除率(CCr)、尿微球蛋白(尿β-MG)、血微球蛋白(血β-MG)的变化情况。结果:总有效率观察组95.1%,对照组73.2%,2组比较,差异有统计学意义(P<0.01)。治疗后观察组BUN、SCr、血β-MG、尿β-MG水平低于对照组,CCr水平高于对照组,2组比较,差异有统计学意义(P<0.01)。结论:在西医常规治疗的基础上给予中药肾通淋汤治疗,临床疗效显著,保护肾功能。
Objective. To investigate the clinical efficacy of integrated Chinese and western medicine in the treatment of chronic pyelonephritis. Methods: Eighty-two cases with chronic pyelonephritis were divided into the control group and the observation group. The patients in the control group were given conventional western medicine treatment, and patients in the observation group were treated with self-purposed Shen tonglin tag on the basis of the treatment of the control group. The treatment covered 3 courses lasting 6 weeks. The efficacy and changes in blood urea nitrogen (BUN), serum creatinine(SCr)and urine β2 micro-globulin(β2-MG) and other indicators were compared after treatment. Result: The total effective rate was 95.1% in the observation group, and was 73.2% in the control group, the difference being significant (P 〈 0.05). The levels of BUN, SCr, blood β-MG, urine β-MG and CCr in the observation group after treatment were obviously better than those in the control group(P 〈 0.05). Conclusion. integrated Chinese and western medicine is capable of significantly improving the effect and protecting renal function.
出处
《新中医》
CAS
2015年第11期85-87,共3页
New Chinese Medicine
关键词
慢性肾盂肾炎
肾通淋汤
临床效果
Chronic Pyelonephritis,, Shen tonglin tang
Clinical efficacy